Avalo Therapeutics (AVTX)
Nasdaq • AVTX • US05338F3064
ORTEX Data Highlights
ORTEX Data Highlights
As of Oct 21, 2026, ORTEX estimated 28.2% of free float sold short, 9.1 days to cover, cost to borrow 0.54%. Sign up for live short interest data.
Market Cap
379m USD | # 6440 in US
Volume
1.55m shares | 23.78m USD
Shares Outstanding
53.63m
Free Float Shares
69.56% | 37.31m
